Practical, Individualized Dosing: 21st Century Therapeutics and the Clinical Pharmacometrician
- 1 July 2010
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 50 (7), 842-847
- https://doi.org/10.1177/0091270009356572
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Bayesian design using adult data to augment pediatric trialsClinical Trials, 2009
- The In Silico Child: Using Simulation to Guide Pediatric Drug Development and Manage Pediatric PharmacotherapyThe Journal of Clinical Pharmacology, 2009
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsClinical Infectious Diseases, 2009
- Prospective Evaluation of the Bayesian Method for Individualizing Tacrolimus Dose Early After Living‐Donor Liver TransplantationThe Journal of Clinical Pharmacology, 2009
- The use of pharmacokinetic models in paediatric onco‐haematology: effects on clinical outcome through the examples of busulfan and cyclosporineFundamental & Clinical Pharmacology, 2008
- A Statistical Framework for Quantile Equivalence Clinical Trials with Application to Pharmacokinetic Studies that Bridge from HIV‐Infected Adults to ChildrenBiometrics, 2008
- Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research SettingsThe Journal of Clinical Pharmacology, 2008
- Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal TransplantationAmerican Journal of Transplantation, 2007
- Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimensBone Marrow Transplantation, 2001
- An Updated Comparison of Drug Dosing MethodsClinical Pharmacokinetics, 1991